octob
seri
meet
author
publish
approach
manag
emesi
dog
devauchel
other
intend
clinic
guid
best
practic
manag
canin
emesi
statement
guidelin
develop
publish
paper
consensu
opinion
necessari
author
expert
opinion
review
detail
evid
emphasis
opinion
guidelin
develop
highlight
evid
lack
contradictori
systemat
search
literatur
perform
site
googl
scholar
web
scienc
pubm
use
term
vomit
emesi
dog
canin
identifi
relev
refer
primari
sourc
avail
paper
publish
peer
review
journal
referenc
relev
inform
fit
search
term
eg
secondari
effect
drug
refer
identifi
standard
manner
quantifi
strength
evid
avail
support
inform
provid
individu
refer
use
support
statement
classifi
accord
scheme
shown
tabl
assign
evid
level
el
appropri
support
text
overal
evid
grade
oeg
given
accord
scheme
tabl
multipl
refer
avail
attempt
ensur
highest
evid
level
cite
sourc
lack
statement
consid
opinion
author
emesi
facilit
sequenc
program
overlap
coordin
event
reduc
risk
advers
consequ
aspir
acid
stomach
content
whilst
achiev
elimin
reflex
control
within
brainstem
central
pattern
gener
loos
term
vomit
centr
locat
area
dorsomedi
retrofaci
nucleu
initi
stimul
inhibit
relev
motor
nuclei
fukuda
koga
fukuda
koga
koga
other
direct
project
region
motor
nuclei
caudal
part
ventral
respiratori
group
identifi
koga
fukuda
reflex
visibl
phase
hypersaliv
retch
expuls
figur
effer
pathway
control
process
includ
vagal
phrenic
nerv
parasympathet
nerv
salivari
gland
somat
motor
nerv
abdomin
muscl
oeg
b
experiment
studi
show
mani
peripher
stimuli
abdomin
structur
initi
emesi
dog
lang
marvig
xu
chen
releas
enterochromaffin
cell
demonstr
canin
gastric
duoden
mucosa
stimul
vagal
affer
via
receptor
fukui
other
fukui
other
seem
pathway
local
modulatori
signal
also
import
lang
other
sanger
andrew
peripher
emetogen
trigger
may
abrog
bilater
vagotomi
effect
enhanc
combin
ablat
greater
splanchnic
nerv
suggest
one
signal
pathway
fukui
other
vagal
affer
carri
peripher
emetogen
signal
enter
rostral
medulla
oblongata
pass
via
solitari
tract
nucleu
solitari
tract
fukuda
koga
koga
fukuda
oeg
b
chemoreceptor
trigger
zone
brainstem
identifi
area
postrema
locat
dorsal
surfac
medulla
oblongata
adjac
caudal
end
fourth
ventricl
chernicki
other
region
lack
barrier
respons
circul
emetogen
number
receptor
type
note
area
postrema
dog
includ
dopamin
stafanini
histamin
bhargava
other
peptid
yy
lesli
other
numer
chemic
induc
emesi
administ
system
also
via
direct
applic
area
postrema
includ
apomorphin
xylazin
prostaglandin
variou
hormon
peptid
brigg
carpent
carpent
other
carpent
other
carpent
brigg
hikasa
other
ablat
area
postrema
inhibit
emetogen
effect
substanc
carpent
brigg
emetogen
signal
area
postrema
excit
neuron
nucleu
solitari
tract
area
subpostrema
central
pattern
gener
vomit
reflex
koga
fukuda
oeg
b
whilst
gener
accept
dog
like
human
suffer
motion
sick
therapeut
manag
mechan
poorli
understood
littl
studi
conder
other
benchaoui
other
boyd
ablat
area
postrema
thought
stop
emetogen
respons
motion
later
critiqu
suggest
lack
specif
ablat
may
damag
associ
structur
possibl
nucleu
solitari
tract
modul
emet
signal
inner
ear
borison
wang
chinn
oeg
mechan
well
input
peripher
vestibular
area
postrema
trigger
stimul
higher
centr
propos
presum
nucleu
tractu
solitariu
clinic
diseas
associ
emesi
dog
summaris
mani
diseas
emesi
trigger
peripher
central
although
may
concomit
activ
chemoreceptor
trigger
zone
condit
eg
uraemia
whilst
gener
consid
mechan
protect
vomit
food
bitch
believ
part
normal
rear
process
korda
oeg
c
emesi
associ
sign
nausea
eg
depress
saliv
lip
lick
increas
swallow
motion
loss
appetit
whilst
clinic
situat
consequ
diseas
process
per
se
emesi
complet
distinguish
persist
sever
emesi
lead
loss
gastrointestin
fluid
electrolyt
consequ
dehydr
hypovolaem
shock
electrolyt
disturb
eg
metabol
acidosisalkalosi
hypokalaemia
boag
other
corneliu
rawl
aspir
pneumonia
occur
secondari
vomit
kogan
other
persist
vomit
prevent
effect
oral
intak
food
like
lead
malnutrit
see
dietari
manag
concomit
problem
must
assess
treat
appropri
part
clinic
manag
dog
emesi
oeg
c
initi
assess
dog
emesi
evalu
gener
health
condit
determin
sever
diseas
process
differenti
treatment
necessari
need
treat
symptomat
need
examin
specif
treatment
addit
initi
assess
may
give
clear
indic
underli
caus
vomit
initi
assess
start
age
breed
gender
dog
age
import
diseas
common
young
dog
eg
ingest
foreign
bodi
foreign
bodi
induc
ileu
capak
other
dietari
indiscret
infecti
diseas
intussuscept
chronic
intestin
johnson
other
diseas
eg
gastric
neoplasia
common
older
dog
gualtieri
gualtieri
other
sautter
hanlon
breed
import
consider
belgian
shepherd
dog
breed
predisposit
gastric
carcinoma
scanziani
other
chronic
hypertroph
pylor
gastropathi
seen
often
certain
toy
breed
belleng
other
walter
other
hypoadrenocortic
nova
scotia
duck
toll
retriev
hugh
other
mani
breed
predilect
mention
diseas
also
gender
predilect
eg
hypoadrenocortic
commonli
seen
femal
dog
kintzer
peterson
diseas
exclus
affect
one
gender
eg
pyometra
prostat
full
complet
histori
essenti
evalu
vomit
dog
inform
obtain
list
tabl
import
distinct
vomit
regurgit
aetiolog
differ
direct
specif
diagnost
test
regurgit
passiv
undigest
food
saliva
return
graviti
wherea
vomit
reflex
accompani
sign
nausea
hypersaliv
activ
abdomin
musculatur
thorough
physic
examin
requir
includ
assess
featur
shown
tabl
signal
histori
physic
examin
clinician
abl
identifi
criteria
concern
might
indic
need
immedi
diagnost
investig
andor
therapi
tabl
oeg
c
misnom
acut
gastriti
commonli
use
describ
syndrom
acut
self
limit
emesi
almost
case
howev
gastric
inflamm
proven
histopatholog
gastriti
frequent
cite
yet
rare
confirm
diagnosi
case
canin
anorexia
emesi
dog
simpl
mild
acut
self
limit
emesi
need
treat
symptomat
mani
anim
serious
ill
may
need
treatment
recent
studi
suggest
dog
emesi
present
veterinari
surgeon
hubbard
other
even
present
veterinari
surgeon
case
acut
self
limit
emesi
aetiolog
never
determin
factor
dietari
indiscret
infecti
agent
toxin
consid
import
caus
sign
resolv
day
without
symptomat
support
therapi
tent
diagnosi
acut
self
limit
emesi
consid
correct
case
investig
consid
necessari
varieti
diagnost
test
may
indic
tabl
oeg
number
potenti
advers
effect
persist
emesi
alreadi
detail
treatment
persist
emesi
reduc
suffer
prevent
complic
whilst
thorough
investig
undertaken
identifi
possibl
treat
underli
caus
decis
treat
emesi
wait
see
problem
resolv
depend
circumst
individu
case
analysi
use
drug
prevent
emesi
need
assess
hubbard
other
author
show
dog
sign
vomit
sign
resolv
less
two
day
clinician
judg
need
investig
treatment
suggest
approach
summar
algorithm
figur
emesi
may
desir
outcom
follow
toxic
ingest
especi
also
effect
indic
gastrointestin
obstruct
minimis
risk
mask
signific
clinic
sign
import
initi
identifi
case
requir
investig
ensur
effect
examin
plan
reassess
progress
case
treat
symptomat
risk
benefit
assess
made
like
success
particular
drug
prevent
treat
emesi
versu
likelihood
drug
induc
advers
effect
veterinarian
consid
initi
treatment
unnecessari
institut
symptomat
manag
suspect
acut
vomit
pet
owner
advis
follow
initi
assess
immedi
need
specif
diagnosi
treatment
therapi
suffici
mani
case
hubbard
other
advis
benefit
effect
therapi
outcom
measur
monitor
see
monitor
use
antiemet
drug
delay
necessari
investig
treatment
deem
necessari
clinician
support
care
patient
emesi
may
includ
fluid
electrolyt
therapi
correct
prevent
dehydr
andor
electrolyt
therapi
though
treat
symptom
often
improv
patient
demeanour
comfort
replac
make
correct
diagnosi
oeg
antiemet
use
symptomat
manag
clinic
manifest
wide
spectrum
differ
diseas
mani
clinic
situat
eg
uraemia
emesi
may
occur
combin
stimuli
central
peripher
rel
import
differ
pathway
may
may
appar
clinic
present
diagnosi
ideal
drug
therefor
prevent
central
peripher
stimuli
vomit
centr
see
section
caus
vomit
addit
persist
andor
sever
emesi
result
signific
fluid
loss
electrolyt
disturb
ideal
antiemet
drug
without
effect
cardiovascular
system
sinc
action
upset
delic
haemodynam
balanc
dehydr
patient
furthermor
drug
wide
therapeut
index
would
desir
particularli
emesi
associ
kidney
liver
diseas
two
major
organ
system
involv
clearanc
drug
bodi
drug
narrow
therapeut
indic
would
unsaf
administ
dog
signific
kidney
liver
dysfunct
addit
central
nervou
system
sedat
might
undesir
drug
use
treat
emesi
chang
central
nervou
system
cn
function
may
make
diagnosi
underli
caus
emesi
assess
progress
dog
condit
difficult
potenti
predispos
advers
event
aspir
final
lack
direct
effect
antiemet
gi
motil
would
desir
case
although
prokinet
effect
may
benefici
condit
chronic
gastriti
recognis
multipl
input
vomit
centr
involv
within
given
pathway
facilitatori
action
number
neurotransmitt
pathway
holi
grail
identifi
one
drug
inhibit
caus
emesi
nausea
never
like
achiev
figur
outlin
drug
target
receptor
distribut
relat
differ
arm
vomit
reflex
tabl
summar
properti
current
avail
antiemet
drug
class
veterinari
medicin
evid
use
dog
help
clinician
select
drug
whose
profil
best
suit
individu
patient
studi
use
provid
evid
statement
made
tabl
experi
dog
use
model
emesi
induc
determin
antiemet
efficaci
clinic
practic
across
europ
number
antiemet
may
use
metoclopramid
oral
infus
domperidon
ondansetron
acepromazin
mani
drug
routin
clinic
use
gener
consid
effect
use
subject
rigor
test
dearth
clinic
evid
support
efficaci
mani
antiemet
drug
field
condit
systemat
search
literatur
antiemet
dog
limit
clinic
trial
yield
paper
true
clinic
trial
involv
field
case
veterinari
practic
moor
other
examin
antiemet
effect
butorphanol
cyproheptadin
clinic
case
lymphoma
receiv
cisplatin
demonstr
butorphanol
moder
effect
valverd
other
demonstr
valu
acepromazin
prevent
emesi
dog
receiv
opiat
part
protocol
three
paper
involv
receptor
antagonist
maropit
de
la
other
conduct
clinic
trial
examin
abil
antiemet
drug
arrest
emesi
due
medic
condit
dog
field
condit
phase
maropit
perform
significantli
better
metoclopramid
term
lower
proport
dog
vomit
administr
antiemet
number
emet
event
record
dog
vomit
vail
other
examin
effect
maropit
frequenc
emesi
clinic
patient
receiv
cisplatin
given
higher
dose
studi
moor
other
demonstr
maropit
prevent
emesi
also
suggest
efficaci
treat
prevent
nausea
induc
chemotherapi
evalu
visual
analogu
scale
final
clinic
trial
also
involv
maropit
examin
abil
prevent
motion
sick
dog
prone
problem
benchaoui
other
larg
multicentr
placebo
control
clinic
trial
demonstr
maropit
reduc
number
dog
vomit
journey
compar
placebo
limit
data
advis
small
anim
clinician
optim
feed
strategi
vomit
patient
two
main
scenario
consid
approach
separ
first
sever
affect
vomit
patient
hospitalis
requir
second
patient
vomit
less
sever
handl
human
wealth
inform
support
use
enter
method
feed
parenter
nutrit
critic
review
zaloga
compar
parenter
nutrit
pn
use
enter
nutrit
en
improv
surviv
decreas
infect
rate
decreas
bacteri
transloc
enabl
earlier
discharg
hospit
cost
effect
howev
examin
benefit
either
enter
nutrit
volit
nutrit
support
nil
per
os
strategi
controversi
suggest
asid
use
volit
nutrit
support
geriatr
patient
studi
demonstr
clear
benefit
koretz
other
numer
studi
avail
detail
methodolog
applic
benefit
complic
en
abood
buffington
michel
higgin
pn
lippert
other
chandler
dog
complet
discuss
inform
outsid
scope
current
review
broadli
speak
techniqu
provid
benefit
hospitalis
associ
variou
complic
notabl
vomit
alimentari
tract
sign
common
complic
enter
method
feed
abood
buffington
thu
one
potenti
benefit
control
nausea
vomit
companion
anim
may
enabl
enter
nutrit
administ
earlier
opportun
lower
associ
morbid
data
clinic
studi
directli
compar
en
pn
dog
alimentari
tract
diseas
howev
extrem
limit
two
experiment
studi
assess
effect
earli
en
pancreat
patholog
featur
gut
barrier
function
dog
experiment
acut
pancreat
qin
other
xu
other
conclus
studi
en
prefer
pn
case
acut
pancreat
clinic
studi
howev
recommend
determin
applic
set
one
randomis
unblind
clinic
studi
compar
effect
earli
enter
nutrit
een
versu
food
withhold
case
parvovir
enter
whose
sign
includ
emesi
mohr
other
een
group
fed
standard
critic
care
diet
via
tube
commenc
hour
hospitalis
contrast
food
withheld
nil
per
os
npo
group
emesi
ceas
trend
toward
improv
surviv
een
group
given
een
dog
surviv
whilst
npo
een
group
also
show
earlier
clinic
improv
rapid
day
improv
demeanour
appetit
vomit
diarrhoea
signific
weight
gain
occur
group
npo
group
whilst
improv
intestin
barrier
function
seen
similar
clinic
studi
assess
benefit
combin
parenter
oral
nutrit
compar
parenter
nutrit
alon
young
dog
haemorrhag
gastroenter
other
dog
altern
alloc
group
treat
least
day
enter
nutrit
group
hydrolys
cottag
chees
base
diet
pancreat
enzym
administ
syring
day
onward
dog
enter
nutrit
group
vomit
within
half
hour
start
feed
second
day
abl
toler
food
better
subsequ
day
signific
differ
gener
health
statu
clinicopatholog
paramet
group
howev
dog
earli
enter
nutrit
group
surviv
compar
parenter
nutrit
group
although
studi
small
latter
find
conjunct
surviv
data
mohr
other
may
suggest
benefit
earli
enter
feed
patient
sever
gastrointestin
diseas
work
would
howev
requir
support
approach
remain
public
either
review
articl
pertain
singl
case
report
small
case
seri
nutrit
support
employ
compon
therapi
patient
sever
gastrointestin
sign
aroch
other
holland
young
other
inform
suggest
earli
enter
nutrit
benefit
interpret
caution
oeg
c
dog
acut
emesi
system
well
common
approach
withhold
food
period
usual
hour
contrast
trend
human
gastroenterolog
continu
feed
face
gastrointestin
sign
clear
evid
continu
feed
gastroenter
advantag
sandhu
equival
publish
studi
assess
rel
merit
food
earli
feed
veterinari
medicin
given
major
dog
acut
gastrointestin
sign
like
diseas
unlik
would
dramat
benefit
detriment
either
method
final
publish
data
examin
dietari
characterist
appropri
acut
vomit
dog
lack
absenc
inform
diet
seem
appropri
oeg
symptomat
manag
institut
prescrib
medic
diet
recommend
veterinarian
administ
initi
limit
hour
treatment
suggest
owner
made
awar
potenti
therapi
mask
emesi
advis
observ
pet
close
contact
veterinari
surgeon
soon
possibl
sign
deterior
andor
patient
get
wors
view
arrang
advis
patient
maximum
hour
continu
emesi
improv
outcom
measur
altern
outcom
measur
includ
appetit
may
reflect
associ
nausea
gener
demeanour
associ
clinic
sign
eg
diarrhoea
stress
owner
return
quickli
concern
clinician
repeat
initi
consult
criteria
treatment
andor
investig
oeg
nausea
vomit
among
fear
complic
chemotherapi
owner
anim
cancer
often
concern
patient
success
treatment
nausea
vomit
anim
cancer
explain
three
main
mechan
ith
localis
tumour
tract
oesophagu
stomach
intestin
liver
pancrea
sullivan
other
wang
other
iiassoci
paraneoplast
syndrom
eg
mastocytoma
apudoma
okeef
other
zerb
other
iiith
treatment
surgeri
radiotherapi
importantli
chemotherapi
gyli
other
discuss
nausea
vomit
origin
chemotherapi
dog
treatment
chang
time
better
understand
pathophysiolog
insight
relationship
differ
drug
use
cancer
chemotherapi
final
develop
new
drug
oeg
c
three
type
vomit
due
cancer
chemotherapi
distinguish
ianticip
vomit
frequent
seen
human
medicin
rare
domest
anim
correspond
type
reflex
depend
memori
eg
visual
stimuli
stimuli
odour
relat
clinic
hospitalis
personnel
type
vomit
import
treat
antiemet
chemotherapi
avoid
activ
reflex
whilst
evid
nausea
emesi
condit
respons
human
receiv
chemotherapi
publish
evid
mechan
dogsiiacut
vomit
manifest
first
hour
chemotherapi
caus
either
central
chemoreceptor
trigger
zone
peripher
stimul
predomin
mode
action
cytotox
drugsiiidelay
vomit
start
day
treatment
fukui
yamamoto
mechan
complex
may
attribut
reduct
intestin
motil
alter
intestin
mucosa
releas
hormon
serotonin
norepinephrin
reduct
urinari
cortisol
excret
also
result
accumul
metabolit
cytotox
agent
especi
deriv
platinum
oeg
c
risk
sever
emesi
seen
vari
accord
cytotox
agent
use
may
classifi
heavi
moder
weak
minim
jordan
other
tabl
whilst
human
medicin
accept
protocol
manag
chemotherapi
induc
nausea
vomit
yet
establish
veterinari
medicin
recent
antiemet
commonli
use
treat
emesi
associ
chemotherapi
canin
medicin
metoclopramid
ondansetron
control
clinic
trial
drug
howev
scarc
studi
demonstr
effect
placebo
control
trial
tumour
bear
dog
drug
investig
butorphanol
moder
effect
clinic
case
lymphoma
receiv
cisplatin
ginger
extract
also
test
emesi
dog
suggest
benefit
moor
other
sharma
other
discoveri
eg
ondansetron
led
improv
prevent
acut
emesi
delay
vomit
still
frequent
seen
sagrada
other
small
experiment
trial
emesi
dog
show
ondansetron
granisetron
could
significantli
inhibit
vomit
topal
other
recent
antagonist
maropit
proven
efficaci
prevent
emesi
treatment
cisplatin
clinic
de
la
other
vail
other
oeg
undertak
extens
review
literatur
relat
aetiolog
diagnosi
manag
emesi
dog
emphasis
much
accept
practic
base
littl
evid
much
extrapol
human
medicin
applic
expert
experi
opinion
review
highlight
import
clinic
question
genuin
uncertainti
provid
basi
direct
futur
clinic
studi
author
would
like
acknowledg
help
support
pfizer
anim
health
manufactur
maropit
